Vanderbilt Ingram Cancer Center
Aug. 15, 2019—A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.
Aug. 1, 2019—The Vietnamese Ministry of Health has awarded two Vanderbilt epidemiologists the Memorabilia Medal “For the People’s Health” in appreciation of their contributions in helping the nation establish a population-based research program for cancer, diabetes and other non-communicable diseases.
Aug. 1, 2019—Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes.
Jul. 22, 2019—Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.
Jul. 8, 2019—A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
May. 31, 2019—Breast cancer expert Ben Ho Park, M.D., is the new director of Precision Oncology at Vanderbilt-Ingram Cancer Center. Dr. Park explains his groundbreaking research on the genetic events that lead to cancer, and what that means for the future of cancer treatment.
May. 6, 2019—New research by School of Nursing professor Sheila Ridner finds that a special scan measuring lymphatic fluid volume is significantly better than a tape measure at predicting which women undergoing treatment for breast cancer are at risk of developing a common complication resulting from damaged lymph nodes.